Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection With Proposed Merger With TuHURA Biosciences, Trading to Begin Under New Name and Symbol "HURA" on October 17, Reducing Outstanding Shares to 1.6M
Portfolio Pulse from Benzinga Newsdesk
Kintara Therapeutics is implementing a 1-for-35 reverse stock split as part of a proposed merger with TuHURA Biosciences. The company will trade under the new name and symbol 'HURA' starting October 17, reducing outstanding shares to 1.6 million.
October 16, 2024 | 3:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Kintara Therapeutics is undergoing a 1-for-35 reverse stock split in preparation for a merger with TuHURA Biosciences. This will reduce the number of outstanding shares to 1.6 million and the company will trade under the new symbol 'HURA' starting October 17.
The reverse stock split is a significant corporate action that will affect the stock price by reducing the number of shares, potentially increasing the stock price per share. The merger with TuHURA Biosciences and the new trading symbol 'HURA' are likely to attract investor attention, possibly leading to increased volatility and interest in the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100